angiotensin ii has been researched along with Obesity in 203 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (7.39) | 18.7374 |
| 1990's | 17 (8.37) | 18.2507 |
| 2000's | 85 (41.87) | 29.6817 |
| 2010's | 73 (35.96) | 24.3611 |
| 2020's | 13 (6.40) | 2.80 |
| Authors | Studies |
|---|---|
| Bandinelli, M; Boddi, M; Chiostri, M; Coppo, M; Modesti, PA; Poggesi, L | 1 |
| Gurusamy, N; Sukumaran, V; Venkatesh, S; Yalcin, HC | 1 |
| Cassis, LA; de Beer, FC; Dugan, AJ; Ji, A; Leung, SW; Noffsinger, VP; Shridas, P; Tannock, LR; Thatcher, SE; Trumbauer, AC; Webb, NR | 1 |
| Jiao, XY; Lei, Z; Li, A; Shi, W; Wang, J; Wang, X; Zhang, Y | 1 |
| Barthelemy, J; Bogard, G; Briand, F; Chabrat, A; Deruyter, L; Domenig, O; Heumel, S; Hoffmann, E; Infanti, F; Machelart, A; Nogueiras, R; Pinet, F; Prévot, V; Richard, V; Robil, C; Sencio, V; Sulpice, T; Trottein, F; Wolowczuk, I | 1 |
| Cho, HM; Eto, M; Jung, JK; Kim, JI; Yoon, GE; Youn, EK | 1 |
| Kaga, S; Mori, K; Nakajima, H; Nakamura, S; Ogawa, Y; Okuma, H; Tsuchiya, K; Uchinuma, H | 1 |
| Dai, H; Ding, L; Gao, Q; Kang, Y; Song, T; Wang, F; Xiong, X; Yuan, Y; Zhang, F; Zhou, H; Zhou, Y; Zhu, G | 1 |
| de Boer, RA; Koonen, DPY; Lindtstedt, EL; Michaëlsson, E; Piek, A; Schouten, EM; Silljé, HHW | 1 |
| Cicogna, AC; Corrêa, CR; da Silva-Bertani, DCT; de Oliveira, EM; de Souza, SLB; de Tomasi, LC; Fernandes, T; Freire, PP; Mota, GAF; Padovani, CR; Sant'Ana, PG; Vileigas, DF | 1 |
| Cui, SX; Doviak, H; Epstein, FH; French, BA; Leor, J; Sano, S; Shah, SA; Walsh, K; Wang, Y; Waters, CD | 1 |
| Feng, P; Huang, H; Kong, Y; Li, C; Li, S; Liang, B; Lin, Y; Qiu, M; Wang, W; Zhao, X; Zhu, Q | 1 |
| Fujita, T; Kawarazaki, W | 1 |
| Alatawi, Y; Alghamdi, BS; Alshehri, FS; Balabagno, AO; Chen, Y; Durmanova, V; Evangelista, LS; Hromadka, T; Javor, J; Ji, Q; Jiao, J; Kralova, M; Kurdi, M; Labban, S; Li, X; Li, Y; Lv, Q; Minarik, G; Ocenasova, A; Pagsibigan, JS; Parnicka, Z; Reznakova, V; Shawkatova, I; Shen, ZJ; Tian, X; Tu, S; Tuazon, JA; Vaseckova, B; Wang, XY; Wang, Z; Xue, Y; Zeng, LX; Zhang, S; Zhang, ZH; Zuo, C | 1 |
| Pawlikowski, M; Winczyk, K | 1 |
| Chen, XH; Cheng, YW; Gao, PJ; Kong, LR; Lan, BD; Lin, JR; Ruan, CC; Xu, L; Zhang, ZB | 1 |
| Gong, WQ; Huang, WC; Liang, Y; Liu, B; Yang, CM; Ye, XL; Zheng, YT | 1 |
| Boschmann, M; Dahlke, M; Danser, AHJ; Dole, WP; Engeli, S; Jordan, J; May, M; Nussberger, J; Pal, P; Prescott, MF; Stitah, S | 1 |
| Shen, Z; Wang, X; Weng, C; Yang, K; Zhang, Z | 1 |
| Scherer, PE; Zhu, Q | 1 |
| Alarcon, G; Jerez, S; Medina, A; Medina, M; Peral, M; Roco, J | 1 |
| Huang, LT; Lin, IC; Lin, YJ; Sheen, JM; Tain, YL; Tiao, MM; Tsai, CC; Tsai, WL; Yu, HR | 1 |
| Abraham, NG; Arad, M; Aravot, D; Cohen, K; Gorfil, D; Hochhauser, E; Kornwoski, R; Laniado-Schwartzman, M; Nudelman, V; Waldman, M; Yadin, D | 1 |
| Becker, BK; De Miguel, C; Loria, AS; Obi, IE; Pollock, DM; Pollock, JS; Speed, JS; Spradley, FT | 1 |
| Llinas, MT; Martinez, CM; Moreno, JM; Oltra, L; Reverte, V; Salazar, FJ; Tapia, A | 1 |
| AlSiraj, Y; Cassis, LA; Chen, J; Shoemaker, R | 1 |
| da Silva, AA; do Carmo, JM; Hall, JE; Hall, ME; Wang, Z | 1 |
| Américo, ALV; Evangelista, FS; Fonseca-Alaniz, MH; Martucci, LF; Muller, CR; Vecchiatto, B | 1 |
| Bandinelli, M; Boddi, M; Chiostri, M; Coppo, M; Poggesi, L | 1 |
| Arad, M; Aravot, D; Hochhauser, E; Kornwoski, R; Nudelman, V; Peterson, SJ; Shainberg, A; Waldman, M; Zemel, R | 1 |
| Almeida Colombari, DS; Barbosa, RM; Colombari, E; De Luca, LA; Menani, JV; Sá, JM | 1 |
| de Kloet, AD; Frazier, CJ; Herman, JP; Hiller, H; Krause, EG; Pati, D; Seeley, RJ; Sumners, C; Wang, L; Woods, SC | 1 |
| Burnett, R; Charvat, TT; Dorrance, AM; Fink, GD; Penfold, ME; Rourke, JL; Seitz, B; Sinal, CJ; Sullivan, TJ; Thompson, JM; Watts, SW | 1 |
| Eshraghian, M; Farhangi, MA; Keshavarz, SA; Ostadrahimi, A; Saboor-Yaraghi, AA | 1 |
| Andersen, UB; Asferg, CL; Christiansen, M; Esler, M; Goetze, JP; Hedley, PL; Jeppesen, JL; Linneberg, A; Møller, DV; Nielsen, SJ | 1 |
| Ahmed, SB; Hemmelgarn, BR; Macrae, JM; Mann, MC; Nicholl, DD; Sola, DY; Turin, TC; Zalucky, AA | 1 |
| Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H | 1 |
| de Kloet, AD; Hiller, H; Nguyen, D; Pioquinto, DJ; Smith, JA; Sumners, C; Wang, L | 1 |
| Howitt, L; Morris, MJ; Murphy, TV; Sandow, SL | 1 |
| Hasan, AU; Hashimoto, T; Ishihara, N; Ishihara, Y; Kamitori, K; Kohno, M; Noma, T; Ohmori, K; Tokuda, M; Yamaguchi, F | 1 |
| Cheng, XW; Dai, Q; Hao, C; Murohara, T; Wu, H; Yao, H; Zhang, Z | 1 |
| Amaral, LS; Belo, NO; Coimbra, TM; Macedo, CL; Magalhaes, AC; Ribas, WB; Silva, JA; Soares, TJ; Trindade, TM | 1 |
| Akamine, EH; Aragão, DS; Carvalho, MH; Casarini, DE; Filgueira, FP; Fortes, ZB; Hagihara, GN; Lobato, NS | 1 |
| Bagi, Z; Czikora, I; Feher, A; Fulton, DJ; Lucas, R | 1 |
| Byrne, D; Martino, HS; Mertens-Talcott, SU; Noratto, G; Simbo, S | 1 |
| Bader, M; Barkhausen, J; Raasch, W; Santos, RA; Schuchard, J; Schuster, F; Stölting, I; Thorns, C; Vogt, FM; Winkler, M | 1 |
| Eskurza, I; Hosooka, T; Jiang, H; Kahn, BB; Kraus, BJ; Lee, SA; Michel, T; Polak, P; Sartoretto, JL; Shiroto, T | 1 |
| Balbo, SL; Franci, CR; Gobo, CG; Menegotto, JB; Paz, ED; Sagae, SC; Yamashita, PK | 1 |
| Alfadda, AA; Gul, R; Luck, C; Lum-Naihe, K; Mahmood, A; Pulakat, L; Speth, RC | 1 |
| Brdar, M; Dear, AE; Gaspari, T; Hu, Y; Lee, HW; Simpson, RW; Spizzo, I; Widdop, RE | 1 |
| Hurr, C; Young, CN | 1 |
| Abraham, NG; Gotlinger, K; Jiang, H; Maher, E; O'Hanlon, K; Peterson, SJ; Shapiro, JI; Singh, SP; Sodhi, K; Vanella, L | 1 |
| Aroor, A; Duta, C; Meuth, A; Nistala, R; Sowers, JR; Whaley-Connell, A; Zuberek, M | 1 |
| Claflin, KE; Gourronc, FA; Grobe, JL; Keen, HL; Klingelhutz, AJ; Littlejohn, NK; Liu, X; Markan, KR; Morgan, DA; Naber, MC; Park, S; Pearson, NA; Potthoff, MJ; Rahmouni, K; Sigmund, CD; Tobin, KV; Weidemann, BJ | 1 |
| Krskova, K; Slamkova, M; Zorad, S | 1 |
| Aiello, EA; Caldiz, CI; Chiappe de Cingolani, G; Cingolani, HE; Correa, MV; Dulce, RA; Ennis, IL; Garciarena, CD; Nolly, MB; Perez, NG; Villa-Abrille, MC; Yeves, AM | 1 |
| Boschmann, M; Contrepas, A; Dechend, R; Engeli, S; Graeske, S; Gratze, P; Janke, J; Klaus, S; Luft, FC; Malchow, J; Muller, DN; Nguyen, G; Plehm, R; Qadri, F; Springer, J | 1 |
| Ke, L; Lu, ZM; Yu, YR; Zhang, XE; Zhang, XX | 1 |
| Bernlohr, DA; Brintnall, JA; Fowler, JD; Haroldson, TA; Herrera, JE; Johnson, ND; Katz, SA | 1 |
| Endo, K; Koide, N; Miyashita, Y; Murano, T; Ohira, M; Oyama, T; Saiki, A; Shirai, K; Watanabe, H | 1 |
| Budge, H; Fainberg, HP; Gardner, DS; Harvey, E; Sharkey, D; Symonds, ME; Wilson, V | 1 |
| Cassis, LA; Charnigo, R; Daugherty, A; Police, SB; Thatcher, SE | 1 |
| Elmarakby, AA; Imig, JD | 1 |
| Begg, DP; Jois, M; Weisinger, RS | 1 |
| Day, RO; Graham, GG; Indraratna, PL; Williams, KM | 1 |
| Bader, M; Diedrich, A; Goncalves, AC; Gross, V; Hilzendeger, AM; Pesquero, JB; Plehm, R | 1 |
| Batifoulier-Yiannikouris, F; Cassis, LA; Daugherty, A; Police, SB; Putnam, K; Thatcher, S | 1 |
| Rizvi, AA | 1 |
| Abe, S; Azekoshi, Y; Momomura, S; Tagawa, T; Ueda, S; Uehara, Y; Urata, H; Watanabe, S; Yamakawa, K; Yasu, T | 1 |
| Ecelbarger, CM; Jose, PA; Li, F; Wang, X | 1 |
| Forman, JP; Vaidya, A; Williams, JS | 1 |
| Aavula, BR; Anandan, SK; Cases, S; Chen, D; Cheng, Y; Do, ZN; Gless, R; Hammock, BD; Jones, PD; MacIntyre, DE; Mehra, U; Patel, DV; Sabry, J; Tran, V; Vincelette, J; Wang, YX; Waszczuk, J; Webb, HK; Whitcomb, R; White, K; Wong, KR; Zhang, LN | 1 |
| Huber, DA; Schreihofer, AM | 1 |
| Bizzarri, A; Blaak, EE; Cajlakovic, M; Clément, K; Cleutjens, JP; Essers, Y; Goossens, GH; Jocken, JW; Konings, E; Ribitsch, V; Venteclef, N | 1 |
| de Bruno, MP; Jerez, S; Karbiner, S; Scacchi, F; Sierra, L | 1 |
| Jöhren, O; Miesel, A; Müller-Fielitz, H; Raasch, W; Vogt, FM | 1 |
| Pan, H; Sun, X; Tan, H; Yu, Y | 1 |
| Burnier, M; Waeber, B; Wuerzner, G | 1 |
| Araki, H; Araki, S; Chin-Kanasaki, M; Deji, N; Haneda, M; Isshiki, K; Kashiwagi, A; Koya, D; Kume, S; Maegawa, H; Nishiyama, A; Tanaka, Y; Uzu, T | 1 |
| Denton, KM; Eppel, GA; Evans, RG; Head, GA | 1 |
| Boydens, C; Decaluwé, K; Maenhaut, N; Pauwels, B; Van de Voorde, J | 1 |
| Jöhren, O; Lau, M; Müller-Fielitz, H; Raasch, W; Schwaninger, M; Stellmacher, F | 1 |
| Boustany-Kari, CM; Cassis, LA; Gupte, M; Karounos, M; Shoemaker, R; Thatcher, SE; Yiannikouris, F; Zhang, X | 1 |
| Forman, JP; Larson, C; Sun, B; Vaidya, A; Williams, JS | 1 |
| Ali, Q; Hussain, T; Sabuhi, R; Samuel, P; Wu, Y | 1 |
| Beyer, AM; Fredrich, K; Lombard, JH; Raffai, G; Weinberg, B | 1 |
| Kusumoto, K | 1 |
| Chen, WW; Gao, XY; Han, Y; Xiong, XQ; Zhang, F; Zhou, YB; Zhu, GQ | 1 |
| Barretti, DL; do Carmo, EC; Fernandes, T; Irigoyen, MC; Magalhães, Fde C; Negrão, CE; Oliveira, EM; Rosa, KT | 1 |
| Müller-Fielitz, H; Raasch, W | 1 |
| Annes, JP; Forman, JP; Sun, B; Underwood, PC; Vaidya, A; Williams, GH; Williams, JS | 1 |
| Adler, GK; Underwood, PC | 1 |
| Al-Attas, OS; Al-Daghri, NM; Alkharfy, KM; Alokail, MS; Bindahman, LS; Draz, HM; Harte, AL; McTernan, PG; Mohamed, AO; Saleem, TH; Yakout, S | 1 |
| DiBona, GF | 1 |
| Abdulkareem, A; Al-Daghri, N; Alenad, AM; Alnaami, AM; Alokail, MS; Chrousos, GP; Draz, HM; Sabico, S; Yakout, SM | 1 |
| Bartness, TJ; DiGirolamo, M; Hausman, DB; Hausman, GJ; Martin, RJ | 1 |
| Díez, J; Fortuño, A; Frühbeck, G; Gómez-Ambrosi, J; Muñiz, P; Rodríguez, A; Salvador, J | 1 |
| Engeli, S; Gorzelniak, K; Janke, J; Luft, FC; Sharma, AM | 1 |
| Gaede, P; Jensen, GV; Larsen, N; Parving, HH; Pedersen, O; Vedel, P | 1 |
| Becker, M; Hussain, T; Lokhandwala, MF; Umrani, D | 1 |
| Blaak, EE; Goossens, GH; van Baak, MA | 1 |
| Ailhaud, G; Boschmann, M; Engeli, S; Gorzelniak, K; Janke, J; Massiéra, F; Schling, P; Sharma, AM; Teboul, M | 1 |
| Barton, M; Carmona, R; Krieger, JE; Ortmann, J; Traupe, T | 1 |
| Gaede, PH; Jensen, GV; Jepsen, PV; Larsen, JN; Parving, HH; Pedersen, OB | 1 |
| Díez, J; Fortuño, A; Frühbeck, G; Gómez-Ambrosi, J; Rodríguez, A | 1 |
| Calegari, VC; Carvalheira, JB; Franchini, KG; Guimarães, RB; Nadruz, W; Ribeiro, EB; Saad, MJ; Velloso, LA; Zecchin, HG | 1 |
| Barthel, A; Bornstein, SR; Ehrhart-Bornstein, M; Hauner, H; Lamounier-Zepter, V; Langenbach, J; McCann, SM; Scherbaum, WA; Schraven, A; Willenberg, HS | 1 |
| Grisk, O; Rettig, R | 1 |
| Frohlich, ED; Sowers, JR | 1 |
| Simon, G | 1 |
| Blaak, EE; Goossens, GH; Saris, WH; van Baak, MA | 1 |
| Barinas-Mitchell, E; Cottam, DR; Eid, G; Kelley, DE; Kuller, L; Mattar, SG; Schauer, PR | 1 |
| Böhnke, J; Engeli, S; Ghose, N; Gorzelniak, K; Janke, J; Lindschau, C; Luft, FC; Sharma, AM | 1 |
| Dong, J; Fujii, S; Furumoto, T; Goto, D; Imagawa, S; Kitabatake, A; Mishima, T; Nakai, Y; Sobel, BE; Zaman, AK | 1 |
| Halliwill, JR; Jensen, MD; Joyner, MJ; Nielsen, S | 1 |
| Al-Hazimi, AM; Syiamic, AY | 1 |
| Edmonds, L; Evans, C; Gillis, D; Hanevold, C; Harshfield, GA; Kapuka, G; Mackey, L; Ortiz, L; Wilson, ME | 1 |
| Fujita, T; Hirata, Y; Kitamura, T; Nagai, R; Nishimatsu, H; Omata, M; Satonaka, H; Suzuki, E; Takeda, R | 1 |
| Hakam, AC; Hussain, T | 1 |
| Hauner, H | 1 |
| Araiza, A; Dincer, UD; Knudson, JD; Kuo, L; Setty, S; Tune, JD; Zhang, C | 1 |
| Leiter, LA; Lewanczuk, RZ | 1 |
| Bloch-Faure, M; Even, P; Ferre, P; Guerre-Millo, M; Moustaid-Moussa, N; Quignard-Boulange, A; Yvan-Charvet, L | 1 |
| du Toit, EF; Lochner, A; Nabben, M | 1 |
| Chetty, R; Coppack, S; Harte, A; Katz, J; Kumar, S; McTernan, P; Smith, S | 1 |
| Clasen, R; Clemenz, M; Foryst-Ludwig, A; Kintscher, U; Krikov, M; Schupp, M; Sprang, C; Thöne-Reineke, C; Unger, T | 1 |
| Nagaria, AM; Reddy, S; Savin, VJ; Sharma, M; Sharma, R; Wiegmann, TB | 1 |
| Hussain, T; Shah, S | 1 |
| Adams, F; Boschmann, M; Franke, G; Jordan, J; Klaus, S; Luft, FC; Schaller, K; Sharma, AM | 1 |
| Arner, P; Blaak, EE; Goossens, GH; Saris, WH; van Baak, MA | 1 |
| Hirata, Y; Hirono, Y; Sugiyama, T; Tateno, T; Tsuchiya, K; Yoshimoto, T | 1 |
| Javadov, S; Karmazyn, M; Kirshenbaum, LA; Purdham, DM; Rajapurohitam, V | 1 |
| Argentino, DP; Dominici, FP; Muñoz, MC; Toblli, JE; Turyn, D | 1 |
| Fukuda, N | 1 |
| Ansurudeen, I; Bornstein, SR; Ehrhart-Bornstein, M; Kopprasch, S; Lamounier-Zepter, V; Rotthoff, T; Scherbaum, WA | 1 |
| Fujita, K; Funahashi, T; Hibuse, T; Hiuge, A; Kihara, S; Kumada, M; Kurata, A; Kuriyama, H; Maeda, N; Nishizawa, H; Ohashi, K; Okada, T; Shimomura, I; Sonoda, M; Yasui, A | 1 |
| Eguchi, S; Suzuki, H | 1 |
| Hussain, T; Siddiqui, AH | 1 |
| Barton, M; Bhattacharya, I; Haas, E; Hofmann-Lehmann, R; Kretz, M; Minotti, R; Mundy, AL; Widmer, CC | 1 |
| Blaak, EE; Goossens, GH; Jocken, JW; Saris, WH; Schiffers, PM; van Baak, MA | 1 |
| Ageno, W; Dentali, F; Romualdi, E | 1 |
| Begg, DP; Chen, N; Jois, M; Mathai, ML; Sinclair, AJ; Weisinger, RS | 1 |
| Ayajiki, K; Kashiwagi, A; Masada, M; Nishio, Y; Okamura, T; Shinozaki, K; Yoshida, Y | 1 |
| Goralski, KB; Sinal, CJ | 1 |
| Dominiak, P; Jöhren, O; Müller, H; Raasch, W; Schweitzer, N | 1 |
| Acuña, MJ; Albala, C; Brücher, R; Cifuentes, M; Rojas, CV | 1 |
| Kawecka-Jaszcz, K; Pośnik-Urbańska, A | 1 |
| Falconetti, C; Fernette, B; Omouessi, ST; Thornton, SN | 1 |
| Boesen, EI; Hair, CD; Mintz, JD; Pollock, DM; Stepp, DW; Sullivan, JC | 1 |
| Bartness, TJ; Bowers, RR; Deng, J; Harp, JB; Hua, K; Kim, HS; Li, F; Takahashi, N; Wang, CH | 1 |
| Fu, X; Huang, HW; Huang, JX; Lin, RJ; Liu, XQ; Peng, DX; Tan, SQ; Wu, SH | 1 |
| Eringa, EC; Roos, MH; Tangelder, GJ; Ter Wee, PM; van Lambalgen, TA; van Rodijnen, WF | 1 |
| Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE | 1 |
| Barton, M; Bhattacharya, I; Kretz, M; Mundy, AL; Widmer, CC | 1 |
| Ecelbarger, CM; Hu, X; Madala Halagappa, VK; Riazi, S; Tiwari, S | 1 |
| Barton, M; Damjanovic, M | 1 |
| Abel, ED; Buchanan, J; Cooksey, RC; Tabbi-Anneni, I | 1 |
| Drury, PL | 1 |
| Hamet, P | 1 |
| Gaboury, CL; Hollenberg, NK; Seely, EW; Simonson, DC; Williams, GH | 1 |
| Harker, CT; Kasiske, BL; Katz, SA; Keane, WF; O'Donnell, MP | 1 |
| Cassis, LA | 2 |
| Abel, MA; Zemel, MB | 1 |
| Collins, LA; Douglas, JG; Ernsberger, P; Koletsky, RJ | 1 |
| Dluhy, RG; Hallouin, MC; Hollenberg, NK; Hopkins, PN; Jeunemaitre, X; Lalouel, JM; Lifton, RP; Skuppin, J; Williams, CS; Williams, GH; Williams, RR | 1 |
| Batlouni, M | 1 |
| Fickova, M; Kral, JG; Macho, L; Zelezna, B; Zorad, S | 1 |
| Alonso-Galicia, M; Brands, MW; Hall, JE; Zappe, DH | 1 |
| Jones, BH; Moustaid, N; Standridge, MK | 1 |
| Choi, Y; Choo, JA; Gwon, HC; Huh, JE; Kim, DK; Kim, JW; Kim, S; Lee, WR; Rhee, CH; Ryu, JC | 1 |
| Corradi, L; Fogari, R; Lazzari, P; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Jensen, JD; Kristensen, K; Richelsen, B | 1 |
| Małyszko, J; Myśliwiec, M; Zbroch, E | 1 |
| Masana Marín, L; Valero Capilla, FA | 1 |
| Barton, M; Carmona, R; d'Uscio, LV; Goettsch, W; Haudenschild, CC; Hillen, H; Krieger, JE; Lattmann, T; Lüscher, TF; Morawietz, H; Münter, K; Shaw, S | 1 |
| Carlson, SH; Shelton, J; White, CR; Wyss, JM | 1 |
| Bokil, HS; Porter, JP | 1 |
| Kim, S; Moustaid-Moussa, N | 1 |
| Ailhaud, G; Fukamizu, A; Massiera, F; Negrel, R; Saint-Marc, P; Teboul, M | 1 |
| Blüher, M; Kratzsch, J; Paschke, R | 1 |
| Holycross, BJ; McCune, SA; Radin, MJ; Sharkey, LC | 1 |
| Hauner, H; Lee, YM; Röhrig, K; Skurk, T | 1 |
| Davydov, AA; Miagkova, MA; Pogozheva, AV | 1 |
| Eszlinger, M; Fasshauer, M; Klein, J; Neumann, S; Paschke, R | 1 |
| Ficková, M; Jezová, D; Krizanová, O; Macho, L; Pintérová, L; Zelezná, B; Zórad, S | 1 |
| Frisbee, JC; Stepp, DW | 1 |
| Armas-Hernandez, MJ; Bolívar, A; Contreras, F; Fouillioux, C; Hernández-Hernández, R; Simonovis, N; Velasco, M | 1 |
| Brown, JJ; Leckie, B; Lever, AF; Morton, JJ; Robertson, JI; Tree, M | 1 |
| Ajzen, H; Gelman, A; Korn, D; Ramos, OL; Sigulem, D | 1 |
| Cugini, P; Mancini, A; Manconi, R; Meucci, T; Serdoz, R | 1 |
| Hems, DA | 2 |
| Peuler, JD; Simpson, L; Sowers, JR; Zemel, MB | 1 |
| Ball, DL; DeRemer, S; Goodfriend, TL; Moorehead, C; Rocchini, AP | 1 |
| Brickman, AS; Sowers, JR; Stern, N | 1 |
| Coleman, TG; Hall, JE; Mizelle, HL | 1 |
| de Champlain, J; Verdy, M | 1 |
| García Torres, JA | 1 |
| Stasiakowa, L | 2 |
| Borgia, C; Iacobelli, A; Scavo, D | 1 |
| Marc-Aurele, J; Verdy, M | 1 |
40 review(s) available for angiotensin ii and Obesity
| Article | Year |
|---|---|
Understanding diabetes-induced cardiomyopathy from the perspective of renin angiotensin aldosterone system.
Topics: Angiotensin II; Animals; Autophagy; Diabetic Cardiomyopathies; Humans; Inflammation; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin-Angiotensin System | 2022 |
Kidney and epigenetic mechanisms of salt-sensitive hypertension.
Topics: Aging; Aldosterone; Angiotensin II; Animals; DNA Methylation; Fetal Nutrition Disorders; Glucuronidase; Humans; Hypertension; Klotho Proteins; Obesity; Oxidative Stress; Receptors, Mineralocorticoid; Renal Circulation; Sodium Chloride, Dietary; Wnt Signaling Pathway | 2021 |
Endocrine and metabolic aspects of COVID-19.
Topics: Aging; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Diabetes Mellitus; Humans; Melatonin; Obesity; Renin-Angiotensin System | 2021 |
Immunologic and endocrine functions of adipose tissue: implications for kidney disease.
Topics: Adipokines; Adiponectin; Adipose Tissue; AMP-Activated Protein Kinases; Angiotensin II; Angiotensinogen; Ceramidases; Diabetes Mellitus, Type 2; Humans; Inflammation; Kidney Diseases; Leptin; Macrophages; Obesity; Receptors, Adiponectin; Signal Transduction | 2018 |
Obesity, kidney dysfunction and hypertension: mechanistic links.
Topics: Adipokines; Aldosterone; Angiotensin II; Humans; Hypertension; Kidney; Kidney Tubules; Leptin; Obesity; Oxidative Stress; Pro-Opiomelanocortin; Receptor, Melanocortin, Type 4; Receptors, Mineralocorticoid; Renal Reabsorption; Renin; Sodium; Sympathetic Nervous System | 2019 |
Neural Control of Non-vasomotor Organs in Hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Central Nervous System; Humans; Hypertension; Obesity; Reactive Oxygen Species | 2016 |
Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females.
Topics: Adipocytes; Adipogenesis; Adiponectin; Adult; Angiotensin II; Blood Pressure; Body Mass Index; Case-Control Studies; F2-Isoprostanes; Female; Gene Expression Regulation; Heme Oxygenase-1; Humans; Hydroxyeicosatetraenoic Acids; Lipoproteins, LDL; Metabolic Syndrome; Middle Aged; Obesity; Primary Cell Culture; Tumor Necrosis Factor-alpha | 2016 |
Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity.
Topics: Adipose Tissue; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Prorenin Receptor; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction | 2016 |
Early signals after stretch leading to cardiac hypertrophy. Key role of NHE-1.
Topics: Adult; Angiotensin II; Biomechanical Phenomena; Cardiomegaly; Heart Ventricles; Humans; Hypertrophy, Right Ventricular; Obesity; Pressoreceptors; Reactive Oxygen Species; Signal Transduction; Sodium-Hydrogen Exchangers; Ventricular Function | 2008 |
Antagonists of the renin-angiotensin system and the prevention of obesity.
Topics: Adipose Tissue; Adiposity; Angiotensin II; Angiotensinogen; Animals; Body Weight; Disease Models, Animal; Humans; Obesity; Receptors, Angiotensin; Renin-Angiotensin System | 2009 |
Critical review of cancer risk associated with angiotensin receptor blocker therapy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Clinical Trials as Topic; Humans; Hypertension; Meta-Analysis as Topic; Neoplasms; Neovascularization, Pathologic; Obesity; Receptors, Angiotensin; Risk Factors | 2011 |
[In vitro and in vivo pharmacological profiles of a novel angiotensin type 1-receptor blocker, azilsartan].
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypertension; Insulin Resistance; Obesity; Oxadiazoles | 2012 |
The renin angiotensin aldosterone system and insulin resistance in humans.
Topics: Adipose Tissue; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Blood Pressure; Glucose; Hemodynamics; Humans; Insulin Resistance; Models, Animal; Muscle, Skeletal; Obesity; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2013 |
Sympathetic nervous system and hypertension.
Topics: Angiotensin II; Animals; Baroreflex; Blood Pressure; Carotid Body; Disease Models, Animal; Humans; Hypertension; Kidney; Obesity; Rabbits; Rats; Sympathetic Nervous System; Vasoconstrictor Agents | 2013 |
The biology of white adipocyte proliferation.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Cell Division; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Macrophage Colony-Stimulating Factor; Obesity; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2001 |
Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders.
Topics: Adipose Tissue; Angiotensin II; Animals; Humans; Obesity; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System | 2003 |
The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?
Topics: Adipocytes; Adipose Tissue, Brown; Angiotensin II; Angiotensinogen; Animals; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; Mice; Obesity; Peptidyl-Dipeptidase A; Rats; Renin; Renin-Angiotensin System; Thermogenesis | 2003 |
Obesity-associated activation of angiotensin and endothelin in the cardiovascular system.
Topics: Adipocytes; Adiponectin; Angiotensin II; Animals; Endothelin-1; Endothelium, Vascular; Hormones, Ectopic; Humans; Hypertension; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Kidney; Leptin; Mice; Nerve Growth Factor; Obesity; Proteins; Rats; Renin-Angiotensin System; Resistin | 2003 |
Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Animals; Calcium; Cardiovascular Diseases; Cations, Divalent; Endocrine Glands; Intercellular Signaling Peptides and Proteins; Leptin; Obesity; Potassium Chloride; Proteins; Rats; Rats, Wistar | 2003 |
Interactions between the sympathetic nervous system and the kidneys in arterial hypertension.
Topics: Angiotensin II; Animals; Humans; Hypertension; Hypertension, Renovascular; Kidney; Kidney Failure, Chronic; Obesity; Rats; Rats, Inbred SHR; Stress, Psychological; Sympathetic Nervous System | 2004 |
Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
Topics: Angiotensin II; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin; Insulin Resistance; Obesity; Risk Factors | 2004 |
Pathogenesis of structural vascular changes in hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Humans; Hypertension; Obesity; Sodium Chloride, Dietary; Vascular Resistance | 2004 |
The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss.
Topics: Acute-Phase Proteins; Adipose Tissue; Angiotensin II; Angiotensinogen; C-Reactive Protein; Humans; Inflammation; Insulin Resistance; Interleukin-6; Liver; Lymphotoxin-alpha; Morbidity; Obesity; Tumor Necrosis Factor-alpha; Weight Loss | 2004 |
The new concept of adipose tissue function.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Animals; Chemokines; Cytokines; Energy Metabolism; Humans; Models, Biological; Obesity; Plasminogen Activator Inhibitor 1; Tumor Necrosis Factor-alpha | 2004 |
Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Humans; Inflammation; Insulin Resistance; Metabolic Syndrome; Obesity; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System | 2005 |
Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Chromatography; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Glucose; Hyperglycemia; Immunoblotting; Insulin; Insulin Resistance; Kidney; Male; Models, Statistical; Obesity; Proteinuria; Radioimmunoassay; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation | 2006 |
[Development of animal models for the metabolic syndrome with hypertension].
Topics: Angiotensin II; Animals; Disease Models, Animal; Hypertension; Insulin Resistance; Metabolic Syndrome; Mice; Mutation; Obesity; Rats; Rats, Inbred SHR; Receptors, Cell Surface; Receptors, Leptin; Tumor Necrosis Factor-alpha | 2006 |
The problem of obesity: is there a role for antagonists of the renin-angiotensin system?
Topics: Adipose Tissue; Angiotensin II; Angiotensin Receptor Antagonists; Humans; Obesity; Receptors, Angiotensin; Renin-Angiotensin System | 2007 |
Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Animals; Cardiovascular Diseases; Complement Activation; Complement C3a; Complement Factor D; Cytokines; Diabetes Mellitus, Type 2; Fibrinolysis; Humans; Inflammation; Insulin Resistance; Interleukin-6; Leptin; Nicotinamide Phosphoribosyltransferase; Obesity; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Resistin; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Risk Factors; Tumor Necrosis Factor-alpha | 2007 |
[Hypertension in postmenopausal women --selected pathomechanisms].
Topics: Age Factors; Aldosterone; Angiotensin II; Blood Pressure; Body Mass Index; Dyslipidemias; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hypertension; Middle Aged; Obesity; Postmenopause; Renin-Angiotensin System | 2006 |
Fat intake and cardiovascular response.
Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cardiovascular System; Dietary Fats; Endothelin-1; Humans; Nitric Oxide; Obesity; Reactive Oxygen Species; Renin-Angiotensin System; Risk Factors | 2008 |
Diabetes and arterial hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Antihypertensive Agents; Blood Pressure; Catecholamines; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Diuretics; Female; Humans; Hypertension; Insulin; Male; Middle Aged; Obesity; Renin; Sodium; Systole; Vascular Diseases | 1983 |
The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity.
Topics: Adipose Tissue; Angiotensin II; Animals; Dietary Fats; Humans; Hypertrophy; Insulin Resistance; Mice; Obesity; Rats; Receptors, Angiotensin; Renin-Angiotensin System | 1995 |
[The auto- and endocrine function of the adipose tissue. Significance for metabolic complications in obesity].
Topics: Adipose Tissue; Angiotensin II; Angiotensinogen; Fatty Acids, Nonesterified; Gonadal Steroid Hormones; Growth Substances; Humans; Obesity; Plasminogen Activator Inhibitor 1; Prostaglandins; Tumor Necrosis Factor-alpha | 1998 |
[New concepts in the pathogenesis of essential hypertension].
Topics: Adult; Angiotensin II; Child; Diabetes Mellitus, Type 1; Endothelin-1; Humans; Hypertension; Nitric Oxide; Obesity; Poland; Risk Factors; Sodium, Dietary | 1999 |
Fat cell metabolism: insulin, fatty acids, and renin.
Topics: Adipocytes; Angiotensin II; Animals; Fatty Acids; Humans; Hypertension; Insulin; Insulin Resistance; Obesity; Renin; Risk Factors | 2000 |
Secretory, endocrine and autocrine/paracrine function of the adipocyte.
Topics: Adipocytes; Adipose Tissue; Agouti Signaling Protein; Angiotensin II; Appetite Regulation; Autocrine Communication; Cell Differentiation; Eicosanoids; Gene Expression; Homeostasis; Humans; Intercellular Signaling Peptides and Proteins; Leptin; Obesity; Paracrine Communication; Prostaglandins; Proteins | 2000 |
Angiotensinogen, angiotensin II and adipose tissue development.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Angiotensinogen; Epoprostenol; Gene Expression Regulation; Humans; Obesity | 2000 |
Dopamine, hypertension and obesity.
Topics: Angiotensin II; Animals; Dopamine; Dopamine Agonists; Humans; Hypertension; Nitric Oxide; Obesity; Protein Kinase C; Rats; Receptors, Dopamine; Risk Factors; Sodium-Hydrogen Exchangers; Vasopressins | 2002 |
[Symposium on problems of essential arterial hypertension. Etiopathogenesis of essential hypertension].
Topics: Age Factors; Angiotensin II; Arteries; Constriction; Diet; Endocrine Glands; Habits; Humans; Hypertension; Nervous System; Obesity; Racial Groups; Renin; Sex Factors | 1968 |
6 trial(s) available for angiotensin ii and Obesity
| Article | Year |
|---|---|
Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertension.
Topics: Adipose Tissue; Adult; Amides; Amlodipine; Angiotensin II; Antihypertensive Agents; Blood Glucose; Double-Blind Method; Female; Fumarates; Glucose; Humans; Hypertension; Insulin; Lipolysis; Male; Microdialysis; Middle Aged; Muscle, Skeletal; Obesity; Renin; Renin-Angiotensin System | 2017 |
Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cholecalciferol; Drug Resistance; Drug Synergism; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Renal Plasma Flow; Vitamin D Deficiency | 2012 |
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins | 2003 |
[The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes].
Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins | 2003 |
Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects.
Topics: Adipose Tissue; Angiotensin II; Body Weight; Central Nervous System Depressants; Drug Interactions; Ethanol; Glycerol; Humans; Hydralazine; Lipolysis; Male; Microdialysis; Middle Aged; Muscle, Skeletal; Obesity; Regional Blood Flow; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Middle Aged; Obesity; Perindopril | 1998 |
157 other study(ies) available for angiotensin ii and Obesity
| Article | Year |
|---|---|
T Cell-based RAS Activity and Insulin Levels in Obese Subjects with Low Grade Inflammation.
Topics: Angiotensin II; C-Reactive Protein; Cytokines; Humans; Inflammation; Insulin; Insulin Resistance; Obesity; Peptidyl-Dipeptidase A; Renin-Angiotensin System; T-Lymphocytes | 2022 |
Adipocyte-Derived Serum Amyloid A Promotes Angiotensin II-Induced Abdominal Aortic Aneurysms in Obese C57BL/6J Mice.
Topics: Adipocytes; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Disease Models, Animal; Doxycycline; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Obesity; Serum Amyloid A Protein | 2022 |
The gene knockout of angiotensin II type 1a receptor improves high-fat diet-induced obesity in rat via promoting adipose lipolysis.
Topics: Adipose Tissue; Angiotensin II; Animals; Diet, High-Fat; Fatty Acids, Nonesterified; Gene Knockout Techniques; Lipolysis; Obesity; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1 | 2022 |
Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; COVID-19; Cricetinae; Cytokines; Diet; Disease Models, Animal; Dyslipidemias; Humans; Inflammation; Mesocricetus; Non-alcoholic Fatty Liver Disease; Obesity; SARS-CoV-2 | 2022 |
Pathologic HDAC1/c-Myc signaling axis is responsible for angiotensinogen transcription and hypertension induced by high-fat diet.
Topics: Angiotensin II; Angiotensinogen; Animals; Diet, High-Fat; Hypertension; Male; Mice; Mice, Inbred C57BL; Obesity; Proto-Oncogene Proteins c-myc; Signal Transduction | 2023 |
Melanocortin-4 receptor in macrophages attenuated angiotensin II-induced abdominal aortic aneurysm in mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Disease Models, Animal; Leptin; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Obesity; Phosphatidylinositol 3-Kinases; Receptor, Melanocortin, Type 4 | 2023 |
Intermedin in Paraventricular Nucleus Attenuates Ang II-Induced Sympathoexcitation through the Inhibition of NADPH Oxidase-Dependent ROS Generation in Obese Rats with Hypertension.
Topics: Adrenomedullin; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Hypertension; Male; MAP Kinase Signaling System; NADPH Oxidases; Obesity; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sympathetic Nervous System | 2019 |
Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling.
Topics: Angiotensin II; Animals; Diet, High-Fat; Disease Models, Animal; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Intra-Abdominal Fat; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Peroxidase; Severity of Illness Index; Thioxanthenes; Ventricular Remodeling | 2019 |
Increased angiotensin II from adipose tissue modulates myocardial collagen I and III in obese rats.
Topics: Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Collagen Type I; Collagen Type III; Diet, High-Fat; Fibrosis; Losartan; Male; Myocardium; Obesity; Rats; Rats, Wistar; Renin-Angiotensin System | 2020 |
Nitroxide-enhanced MRI of cardiovascular oxidative stress.
Topics: Adenosine; Angiotensin II; Animals; Cardiovascular System; Cyclic N-Oxides; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Myocardial Infarction; Nitrogen Oxides; Obesity; Oxidative Stress; Perfusion; Pyrrolidines | 2020 |
Tubular Mas receptor mediates lipid-induced kidney injury.
Topics: Angiotensin II; Animals; Autophagy; Cell Line; Diet, High-Fat; Endoplasmic Reticulum Stress; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2021 |
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II; Animals; Antithrombins; Atrial Fibrillation; Body Mass Index; Catheter Ablation; Cohort Studies; Dabigatran; Dogs; Embolism; Factor Xa Inhibitors; Female; Genotype; Hemorrhage; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Middle Aged; Norepinephrine; Obesity; Polymorphism, Single Nucleotide; Retrospective Studies; Rivaroxaban; Stroke; Sympathectomy | 2017 |
PDGF-D activation by macrophage-derived uPA promotes AngII-induced cardiac remodeling in obese mice.
Topics: Adipocytes; Angiotensin II; Animals; Heart; Hypertension; Lymphokines; Macrophages; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Mice, Transgenic; Myocardium; Obesity; Platelet-Derived Growth Factor; Urokinase-Type Plasminogen Activator; Ventricular Remodeling | 2021 |
[Irbesartan ameliorates cardiac inflammation in type 2 diabetic db/db mice].
Topics: Actins; Angiotensin II; Animals; Biphenyl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Inflammation; Interleukin-6; Irbesartan; Mice; Obesity; Random Allocation; Real-Time Polymerase Chain Reaction; Signal Transduction; Tetrazoles; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2016 |
Renal sympathetic denervation lowers arterial pressure in canines with obesity-induced hypertension by regulating GAD65 and AT
Topics: Angiotensin II; Animals; Blood Pressure; Dogs; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hypertension; Male; Medulla Oblongata; Obesity; Receptor, Angiotensin, Type 1; Renal Artery; RNA, Messenger; Sympathectomy | 2018 |
High fat diet-induced metabolically obese and normal weight rabbit model shows early vascular dysfunction: mechanisms involved.
Topics: Angiotensin II; Animals; Blood Glucose; Body Weight; Diet, High-Fat; Disease Models, Animal; Endothelium, Vascular; Male; Obesity; Rabbits; Random Allocation; Vasodilation | 2018 |
Combined maternal and postnatal high-fat diet leads to metabolic syndrome and is effectively reversed by resveratrol: a multiple-organ study.
Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Diet, High-Fat; Female; Glucose Tolerance Test; Male; Maternal Nutritional Physiological Phenomena; Metabolic Syndrome; Obesity; Pregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Resveratrol; Sirtuin 1; Triglycerides | 2018 |
Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α'.
Topics: Angiotensin II; Animals; Caloric Restriction; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Hypertension; Male; Mice, Inbred C57BL; Myocardium; Obesity; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1; Ventricular Remodeling | 2018 |
Maternal separation enhances anticontractile perivascular adipose tissue function in male rats on a high-fat diet.
Topics: Adipose Tissue; Angiotensin II; Animals; Aorta, Thoracic; Diet, High-Fat; Male; Maternal Deprivation; Nitric Oxide; Obesity; Rats; Vasoconstriction | 2018 |
Sex-dependent differences in the adverse renal changes induced by an early in life exposure to a high-fat diet.
Topics: Abdominal Fat; Adipokines; Adiposity; Age Factors; Albuminuria; Angiotensin II; Animals; Arterial Pressure; Diet, High-Fat; Disease Progression; Female; Hypertension; Inflammation Mediators; Kidney; Kidney Diseases; Male; Obesity; Rats, Sprague-Dawley; Sex Factors; Time Factors | 2019 |
Pancreatic AT1aR Deficiency Decreases Insulin Secretion in Obese C57BL/6 Mice.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Biomarkers; Blood Glucose; Diet, Fat-Restricted; Diet, High-Fat; Disease Models, Animal; Insulin; Insulin Resistance; Islets of Langerhans; Male; Mice, Inbred C57BL; Mice, Knockout; Obesity; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Secretory Pathway | 2019 |
Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose tissue.
Topics: Adipose Tissue, White; Adiposity; Angiotensin I; Angiotensin II; Animals; Biomarkers; Body Weight; Feeding Behavior; Glucose; Insulin Resistance; Male; Mice, Inbred C57BL; Obesity; Peptide Fragments; Peptides; Physical Conditioning, Animal; Renin-Angiotensin System; RNA, Messenger; Subcutaneous Fat; Thermogenesis; Uncoupling Protein 1 | 2019 |
T-Lymphocyte-Based Renin Angiotensin System in Obesity.
Topics: Adult; Aged; Angiotensin II; Body Mass Index; Case-Control Studies; Cells, Cultured; Female; Gene Expression; Humans; Inflammation; Male; Middle Aged; Obesity; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; T-Lymphocytes | 2019 |
The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Topics: Angiotensin II; Animals; Blood Glucose; Caloric Restriction; Carbazoles; Cardiomegaly; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Heme Oxygenase-1; Male; Malondialdehyde; Mesoporphyrins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Obesity; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Protoporphyrins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Sirtuin 1 | 2019 |
Cardiovascular and hidroelectrolytic changes in rats fed with high-fat diet.
Topics: Angiotensin II; Animals; Blood Pressure; Diet, High-Fat; Drinking; Eating; Hypertension; Injections, Intraventricular; Male; Obesity; Rats; Rats, Sprague-Dawley; Water-Electrolyte Balance | 2019 |
Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against diet-induced obesity.
Topics: Action Potentials; Adipose Tissue; Adrenal Glands; Analysis of Variance; Angiotensin II; Animals; Basic Helix-Loop-Helix Transcription Factors; Body Composition; Body Weight; Brain; Calorimetry; Cardiovascular System; Diet, High-Fat; Disease Models, Animal; Drinking; Eating; Energy Metabolism; Female; Gene Expression Regulation; In Vitro Techniques; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Obesity; Paraventricular Hypothalamic Nucleus; Patch-Clamp Techniques; Receptor, Angiotensin, Type 1; Repressor Proteins; RNA, Messenger; Sodium Chloride; Telemetry | 2013 |
Chemerin connects fat to arterial contraction.
Topics: Adipokines; Adipose Tissue; Angiotensin II; Animals; Aorta, Thoracic; Blotting, Western; Chemokines; Disease Models, Animal; Gene Expression Regulation; Humans; Hypertension; Immunochemistry; Intercellular Signaling Peptides and Proteins; Mesenteric Arteries; Muscle, Smooth, Vascular; Obesity; Phenylephrine; Rats; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Vasoconstriction | 2013 |
White blood cell count in women: relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factors.
Topics: Adipose Tissue; Adult; Angiotensin II; Biomarkers; Blood Platelets; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Female; Humans; Inflammation; Interleukin-6; Intra-Abdominal Fat; Leukocyte Count; Lipids; Obesity; Population Surveillance; Risk Factors; Waist Circumference | 2013 |
Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men.
Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Composition; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Obesity; Prognosis; Renin; Renin-Angiotensin System | 2013 |
Sex influences the effect of body mass index on the vascular response to angiotensin II in humans.
Topics: Adiposity; Adult; Angiotensin II; Blood Pressure; Body Mass Index; Body Weight; Creatinine; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Obesity; Overweight; Renin-Angiotensin System; Risk Factors; Sex Factors; Sodium; Sodium, Dietary; Vasoconstrictor Agents; Waist Circumference; Waist-Hip Ratio; Young Adult | 2014 |
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2014 |
Obesity induces neuroinflammation mediated by altered expression of the renin-angiotensin system in mouse forebrain nuclei.
Topics: Adiposity; Angiotensin II; Animals; Apoptosis Regulatory Proteins; Basic Helix-Loop-Helix Transcription Factors; Body Mass Index; Calcium-Binding Proteins; Cytokines; Diet, High-Fat; Disease Models, Animal; Encephalitis; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Neuroglia; Obesity; Prosencephalon; Renin-Angiotensin System; Repressor Proteins | 2014 |
Effect of diet-induced obesity on BK(Ca) function in contraction and dilation of rat isolated middle cerebral artery.
Topics: Adiposity; Angiotensin II; Animals; Blood Glucose; Diet, High-Fat; Endothelium, Vascular; Male; Middle Cerebral Artery; Nitroprusside; Obesity; Potassium Channels, Calcium-Activated; Rats; Rats, Sprague-Dawley; Receptor, PAR-2; Serotonin; Vasoconstriction; Vasodilation | 2014 |
Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.
Topics: 3T3-L1 Cells; Active Transport, Cell Nucleus; Adipocytes; Adipokines; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Chlorocebus aethiops; COS Cells; Drug Inverse Agonism; Interleukin-6; Mice; NF-kappa B; Obesity; PPAR gamma; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan | 2014 |
Regulation of apelin and its receptor expression in adipose tissues of obesity rats with hypertension and cultured 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apelin; Apelin Receptors; Gene Expression; Gene Expression Regulation; Hypertension; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Obesity; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Tetrazoles | 2014 |
Renal changes in the early stages of diet-induced obesity in ovariectomized rats.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Diet, High-Fat; Energy Intake; Female; Insulin; Kidney; Macrophages; Neutrophil Infiltration; NF-kappa B; Obesity; Ovariectomy; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2014 |
Upregulation of ERK1/2-eNOS via AT2 receptors decreases the contractile response to angiotensin II in resistance mesenteric arteries from obese rats.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Blotting, Western; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Male; Mesenteric Arteries; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Phosphorylation; Pyridines; Rats, Wistar; Receptor, Angiotensin, Type 2; Up-Regulation; Vasoconstriction; Vasoconstrictor Agents | 2014 |
Caveolin-1 prevents sustained angiotensin II-induced resistance artery constriction and obesity-induced high blood pressure.
Topics: Angiotensin II; Animals; Arteries; Caveolae; Caveolin 2; Cell Membrane; Hypertension; Male; Muscle, Smooth, Vascular; Obesity; Protein Binding; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2015 |
Consumption of polyphenol-rich peach and plum juice prevents risk factors for obesity-related metabolic disorders and cardiovascular disease in Zucker rats.
Topics: Angiotensin II; Animals; Biomarkers; Cardiovascular Diseases; Chemokine CCL2; Fruit and Vegetable Juices; Insulin; Intercellular Adhesion Molecule-1; Leptin; Male; Metabolic Syndrome; NF-kappa B; Obesity; Polyphenols; PPAR gamma; Prunus domestica; Prunus persica; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Risk Factors; RNA, Messenger; Weight Gain | 2015 |
Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Benzimidazoles; Benzoates; Diet; Energy Intake; Energy Metabolism; Insulin Resistance; Leptin; Male; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Signal Transduction; Telmisartan; Weight Gain; Weight Loss | 2015 |
Novel role for retinol-binding protein 4 in the regulation of blood pressure.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Obesity; Phosphorylation; Retinol-Binding Proteins, Plasma; Vasodilation | 2015 |
[Blockade of AT1 receptor of Angiotensin II reduces the number of antral follicles in female rats with obesity induced by cafeteria diet].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Diet; Energy Intake; Female; Food Services; Losartan; Obesity; Ovarian Follicle; Random Allocation; Rats; Rats, Wistar | 2015 |
Regulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol.
Topics: Angiotensin II; Animals; Cells, Cultured; Gene Expression Regulation; Male; Mediator Complex; Mice; MicroRNAs; Myocytes, Cardiac; Nebivolol; Obesity; Rats; Rats, Zucker; Signal Transduction; Sirolimus; Weight Gain | 2015 |
Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis.
Topics: Aging; Angiotensin II; Animals; Aorta; Blood Pressure; Body Weight; Chemokine CCL2; Diet, High-Fat; Disease Models, Animal; Endothelium, Vascular; Fibrosis; Glucagon-Like Peptide-1 Receptor; Heart; Heart Diseases; Hypertension; I-kappa B Proteins; Immunohistochemistry; Incretins; Inflammation; Interleukin-10; Liraglutide; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocardium; NF-kappa B p50 Subunit; Obesity; Oxidative Stress; Real-Time Polymerase Chain Reaction; Vasoconstrictor Agents; Vimentin | 2016 |
Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules.
Topics: Angiotensin II; Animals; Cell Line; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Kidney Tubules, Proximal; Low Density Lipoprotein Receptor-Related Protein-2; Male; MAP Kinase Signaling System; Mice; Mice, Obese; Obesity; Renal Insufficiency | 2016 |
Suppression of Resting Metabolism by the Angiotensin AT2 Receptor.
Topics: Adipocytes; Adipose Tissue, White; Angiotensin II; Animals; Brain; Energy Metabolism; Mice, Inbred C57BL; Obesity; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2016 |
Energy metabolism in human renin-gene transgenic rats: does renin contribute to obesity?
Topics: Adipocytes; Amides; Angiotensin II; Animals; Cells, Cultured; Disease Models, Animal; Energy Metabolism; Fumarates; Humans; Leptin; Lipid Metabolism; Male; Obesity; Phenotype; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Thermogenesis | 2009 |
[The effect and pathophysiological mechanism of high free fatty acids(FfAs) on the cardiac structure and function].
Topics: Angiotensin II; Animals; Fatty Acids, Nonesterified; I-kappa B Proteins; Insulin Resistance; Male; Myocardial Contraction; Myocardium; NF-kappa B; Nitric Oxide Synthase Type II; Obesity; Random Allocation; Rats; Rats, Sprague-Dawley; Triglycerides | 2009 |
Regulated renin release from 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Angiotensin II; Animals; Colforsin; Hypoglycemic Agents; Insulin; Interleukin-6; Isoquinolines; Lipolysis; Male; Mice; Mice, Inbred C57BL; Obesity; Protein Kinase Inhibitors; Renin; Renin-Angiotensin System; RNA, Messenger; Stem Cells; Sulfonamides; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2009 |
Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin Resistance; Leptin; Lipoprotein Lipase; Male; Middle Aged; Obesity; Tomography, X-Ray Computed; Weight Loss | 2009 |
Impact of early onset obesity and hypertension on the unfolded protein response in renal tissues of juvenile sheep.
Topics: Analysis of Variance; Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Disease Models, Animal; Disease Progression; Female; Hypertension; Immunohistochemistry; Kidney; Kidney Diseases; Male; Nitric Oxide; Obesity; Proteins; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Sheep; Statistics, Nonparametric; Tissue Culture Techniques | 2009 |
Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation.
Topics: Adipose Tissue; Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Cell Movement; Cytokines; Dietary Fats; Inflammation; Insulin Resistance; Macrophages; Male; Mice; Mice, Inbred C57BL; Obesity; Systole | 2009 |
Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats.
Topics: Acetylcholine; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Cyclooxygenase 2; Dietary Fats; Endothelium, Vascular; Hypertension; I-kappa B Kinase; Insulin Resistance; Kidney; Lipids; Male; Nephritis; NF-kappa B; Nitrites; Obesity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents; Weight Gain | 2010 |
Hyperuricemia, cardiovascular disease, and the metabolic syndrome.
Topics: Angiotensin II; Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Metabolic Syndrome; Obesity; Renin-Angiotensin System; Risk Factors; Uric Acid | 2009 |
Autonomic dysregulation in ob/ob mice is improved by inhibition of angiotensin-converting enzyme.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Disease Models, Animal; Fourier Analysis; Hypertension; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 2010 |
Weight loss in obese C57BL/6 mice limits adventitial expansion of established angiotensin II-induced abdominal aortic aneurysms.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Connective Tissue; Dietary Fats; Disease Models, Animal; Disease Progression; Endoglin; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Obesity; RNA, Messenger; Weight Loss | 2010 |
Hypertension, obesity, and inflammation: the complex designs of a deadly trio.
Topics: Adaptive Immunity; Angiotensin II; Atherosclerosis; Genes, ras; Humans; Hypertension; Inflammation; Insulin Resistance; Metabolic Syndrome; Obesity; Oxidative Stress | 2010 |
Free fatty acid causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin II production in mononuclear and polymorphonuclear cells.
Topics: Adult; Angiotensin II; Endothelium, Vascular; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Humans; Leukocytes, Mononuclear; Male; Neutrophils; Obesity; Reference Values; Renin-Angiotensin System; Young Adult | 2010 |
Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Body Composition; Diet; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Insulin Resistance; Kidney; Male; Obesity; Rats; Rats, Zucker; Receptors, Dopamine; Sex Characteristics; Sodium Chloride, Dietary; Tetrazoles | 2010 |
Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension.
Topics: Angiotensin II; Biomarkers; Blood Pressure; Chi-Square Distribution; Female; France; Humans; Hypertension; Infusions, Parenteral; Male; Middle Aged; Obesity; Renin; Renin-Angiotensin System; Retrospective Studies; Risk Assessment; Risk Factors; United States; Vitamin D; Vitamin D Deficiency; White People | 2011 |
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.
Topics: Adamantane; Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Hypertension; Insulin Resistance; Mice; Obesity; Rats; Urea | 2011 |
Altered regulation of the rostral ventrolateral medulla in hypertensive obese Zucker rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Brain Stem; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Heart Rate; Hypertension; Losartan; Medulla Oblongata; Microinjections; Muscle Tonus; Muscle, Smooth, Vascular; Obesity; Rats; Rats, Zucker; Receptors, GABA-A; Splanchnic Circulation; Sympathetic Nervous System | 2011 |
Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation.
Topics: Adipose Tissue; Angiotensin II; Humans; Hyperoxia; Inflammation; Insulin Resistance; Isoproterenol; Male; Microcirculation; Middle Aged; Mitochondria; Obesity; Oxygen; Oxygen Consumption; Regional Blood Flow; Thinness; Vasoconstrictor Agents; Vasodilator Agents | 2011 |
Vascular hyporeactivity to angiotensin II and noradrenaline in a rabbit model of obesity.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Diet, High-Fat; Disease Models, Animal; Endothelium, Vascular; Glucose Tolerance Test; In Vitro Techniques; Insulin; Isometric Contraction; Lipids; Male; Membrane Potentials; Muscle, Smooth, Vascular; Nitrites; Norepinephrine; Obesity; Rabbits; Vasodilation | 2012 |
Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Corticosterone; Drug Therapy, Combination; Feeding Behavior; Heart Rate; Leptin; Male; Obesity; Ramipril; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain | 2012 |
High free fatty acids level related with cardiac dysfunction in obese rats.
Topics: Angiotensin II; Animals; Biomarkers; Diet, High-Fat; Fatty Acids, Nonesterified; Fenofibrate; Heart Failure; Immunohistochemistry; Male; Myocardial Contraction; Myocardium; NF-kappa B; Nitric Oxide Synthase Type II; Obesity; Random Allocation; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Triglycerides | 2012 |
Role of angiotensin II-mediated AMPK inactivation on obesity-related salt-sensitive hypertension.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Diet, High-Fat; Disease Models, Animal; Hypertension; Kidney; Losartan; Metabolic Syndrome; Metformin; Mice; Mice, Inbred C57BL; Obesity; Phosphorylation; Sodium; Sodium, Dietary | 2012 |
Effects of tempol and candesartan on neural control of the kidney.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Diet; Diet, High-Fat; Dinoprost; Dose-Response Relationship, Drug; Electric Stimulation; Heart Rate; Hematocrit; Kidney; Kidney Function Tests; Male; Obesity; Rabbits; Renal Circulation; Spin Labels; Superoxides; Tetrazoles; Urodynamics | 2012 |
Adipose tissue as regulator of vascular tone.
Topics: Adipocytes; Adipokines; Adipose Tissue; Angiotensin II; Humans; Inflammation Mediators; Muscle, Smooth, Vascular; Obesity; Vascular Diseases | 2012 |
Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Blood Pressure; Hypertension; Male; Obesity; Rats; Rats, Zucker | 2012 |
Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice.
Topics: 3T3-L1 Cells; Adipocytes; Adiposity; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diet, High-Fat; Disease Models, Animal; Estrogens; Female; Gene Expression Regulation, Enzymologic; Hypertension; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Progesterone; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Risk Factors; RNA, Messenger; Sex Factors; Testosterone; Time Factors; Weight Gain | 2012 |
High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.
Topics: Actins; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Hypertension, Renal; Kidney; Kidney Cortex; Male; Mass Spectrometry; Obesity; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Zucker; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin; Sodium, Dietary; Spectrometry, Mass, Electrospray Ionization | 2012 |
Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity.
Topics: Acetylcholine; Angiotensin II; Animals; Body Weight; Diet, High-Fat; Disease Models, Animal; Eating; Endothelium, Vascular; Male; Middle Cerebral Artery; Obesity; Rats; Rats, Inbred Dahl; Renin; Renin-Angiotensin System; Vasodilation; Vasodilator Agents | 2012 |
Enhanced adipose afferent reflex contributes to sympathetic activation in diet-induced obesity hypertension.
Topics: Adipose Tissue, White; Angiotensin II; Animals; Blood Pressure; Capsaicin; Diet, High-Fat; Diterpenes; Enzyme-Linked Immunosorbent Assay; Hypertension; Immunohistochemistry; Lidocaine; Male; Norepinephrine; Obesity; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Reflex; Renin; Sensory System Agents; Sympathetic Nervous System | 2012 |
Effects of aerobic exercise training on cardiac renin-angiotensin system in an obese Zucker rat strain.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Blotting, Western; Echocardiography; Heart; Heart Rate; Male; Myosin Heavy Chains; Obesity; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Rats; Rats, Zucker; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Angiotensin II impairs glucose utilization in obese Zucker rats by increasing HPA activity via an adrenal-dependent mechanism.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Angiotensin II; Animals; Blood Glucose; Corticosterone; Disease Models, Animal; Glucose Intolerance; Glucose Tolerance Test; Hyperglycemia; Hypothalamo-Hypophyseal System; Insulin; Insulin Secretion; Male; Metabolic Syndrome; Obesity; Pituitary-Adrenal System; Random Allocation; Rats; Rats, Zucker; Up-Regulation | 2013 |
The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes.
Topics: Adipokines; Adult; Aged; Angiotensin II; Arterial Pressure; Biomarkers; Calcium; Cholecalciferol; Diabetes Mellitus; Female; Glycated Hemoglobin; Hormones; Humans; Inflammation; Infusions, Intravenous; Male; Middle Aged; Obesity; Renin-Angiotensin System; Resistin; Sodium; Young Adult | 2013 |
Increased circulating ANG II and TNF-α represents important risk factors in obese saudi adults with hypertension irrespective of diabetic status and BMI.
Topics: Adult; Angiotensin II; Blood Pressure; Body Mass Index; Diabetes Complications; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Risk Factors; Saudi Arabia; Tumor Necrosis Factor-alpha | 2012 |
Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?
Topics: Adipokines; Adult; Angiotensin II; Arabs; Biomarkers, Tumor; Blood Pressure; Breast Neoplasms; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cross-Sectional Studies; Early Detection of Cancer; Enzyme-Linked Immunosorbent Assay; Female; Humans; Insulin; Logistic Models; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Obesity; Odds Ratio; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Risk Assessment; Risk Factors; Saudi Arabia; Stress, Physiological; Triglycerides; Tumor Necrosis Factor-alpha | 2013 |
Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta.
Topics: Angiotensin II; Animals; Aorta; Blotting, Western; Calcium; Carrier Proteins; Endothelium, Vascular; Gene Expression; Immunohistochemistry; Leptin; Male; Muscle, Smooth, Vascular; Obesity; Rats; Rats, Wistar; Rats, Zucker; Receptors, Cell Surface; Receptors, Leptin; Reverse Transcriptase Polymerase Chain Reaction; Vasoconstriction | 2002 |
Angiotensin blockade prevents type 2 diabetes by formation of fat cells.
Topics: Adipocytes; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Differentiation; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Telmisartan | 2002 |
Increased renal angiotensin II AT1 receptor function in obese Zucker rat.
Topics: Angiotensin II; Animals; Colforsin; Cyclic AMP; Heterotrimeric GTP-Binding Proteins; Iodine Radioisotopes; Kidney Tubules, Proximal; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sodium-Hydrogen Exchangers | 2003 |
The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; GRB2 Adaptor Protein; Hypoglycemic Agents; Insulin; Insulin Resistance; Janus Kinase 2; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardium; Obesity; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Rats, Zucker; Receptor Cross-Talk; Vasoconstrictor Agents | 2003 |
Human adipocytes secrete mineralocorticoid-releasing factors.
Topics: Adipocytes; Adrenal Cortex; Adult; Aldosterone; Angiotensin II; Base Sequence; Colforsin; Culture Media, Conditioned; Female; Hot Temperature; Humans; Hypertension; In Vitro Techniques; Mineralocorticoids; Models, Biological; Obesity; Phosphoproteins; RNA, Messenger | 2003 |
Regulation of the nitric oxide system in human adipose tissue.
Topics: Adipocytes; Adipose Tissue; Adult; Angiotensin II; Cells, Cultured; Female; Humans; In Vitro Techniques; Insulin; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Obesity; Weight Loss | 2004 |
Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Collagen Type I; Coronary Disease; Coronary Vessels; Fibrosis; Heart Ventricles; Imidazoles; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 9; Mice; Mice, Obese; Obesity; Olmesartan Medoxomil; Phosphorylation; Plasminogen Activator Inhibitor 1; Tetrazoles; Thiazepines; Transforming Growth Factor beta | 2004 |
Vascular response to angiotensin II in upper body obesity.
Topics: Acetylcholine; Adult; Angiotensin II; Blood Glucose; Body Composition; Dose-Response Relationship, Drug; Forearm; Humans; Hypertension; Insulin Resistance; Lipolysis; Male; Nitric Oxide Synthase; Nitroprusside; Obesity; omega-N-Methylarginine; Palmitic Acid; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2004 |
Relationship between plasma angiotensinII, leptin and arterial blood pressure.
Topics: Adult; Angiotensin II; Biomarkers; Body Mass Index; Case-Control Studies; Female; Humans; Hypertension; Leptin; Obesity; Probability; Prognosis; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index | 2004 |
Relationship of body composition to stress-induced pressure natriuresis in youth.
Topics: Absorptiometry, Photon; Adolescent; Angiotensin II; Blood Pressure; Body Composition; Female; Humans; Male; Natriuresis; Obesity; Racial Groups; Sex Factors; Sodium; Stress, Physiological | 2004 |
Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats.
Topics: Adrenomedullin; Angiotensin II; Animals; Aorta; Calcium; Diabetic Angiopathies; Endothelium, Vascular; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Obesity; Peptides; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker; rho GTP-Binding Proteins; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Diuresis; Imidazoles; Kidney; Male; Natriuresis; Obesity; Oligopeptides; Pyridines; Rats; Rats, Zucker; Receptor, Angiotensin, Type 2; Tetrazoles; Up-Regulation | 2005 |
Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors.
Topics: Angiotensin II; Animals; Blood Pressure; Coronary Circulation; Dietary Fats; Dogs; Female; Gene Expression; In Vitro Techniques; Male; Metabolic Syndrome; Obesity; Oxygen Consumption; Physical Exertion; Prediabetic State; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasoconstriction; Vasoconstrictor Agents | 2005 |
Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance.
Topics: Adipocytes; Angiotensin II; Animals; Cell Size; Dietary Fats; Energy Metabolism; Hypertension; Imidazoles; Insulin Resistance; Mice; Mice, Knockout; Muscle, Skeletal; Obesity; Pyridines; Receptor, Angiotensin, Type 2 | 2005 |
A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
Topics: Angiotensin II; Animals; Blood Glucose; Cardiac Output; Cardiomegaly; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Obesity; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2005 |
Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone.
Topics: Adipocytes; Angiotensin II; Antihypertensive Agents; Cells, Cultured; Drug Antagonism; Humans; Insulin; Obesity; Renin-Angiotensin System; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |
PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
Topics: 3T3-L1 Cells; Adipocytes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Cycloheximide; Insulin Resistance; Irbesartan; Mice; Obesity; PPAR gamma; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Rats; Rats, Zucker; Receptor, Angiotensin, Type 2; Telmisartan; Tetrazoles | 2005 |
Enhanced angiotensin II-induced activation of Na+, K+-ATPase in the proximal tubules of obese Zucker rats.
Topics: Angiotensin II; Animals; Enzyme Activation; GTP-Binding Proteins; Hypertension; In Vitro Techniques; Kidney Tubules, Proximal; Male; Natriuresis; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 2006 |
Hemodynamic and metabolic responses to interstitial angiotensin II in normal weight and obese men.
Topics: Adipose Tissue; Adult; Angiotensin II; Humans; Infusions, Parenteral; Male; Microdialysis; Obesity; Quadriceps Muscle | 2006 |
Angiotensin II: a hormone that affects lipid metabolism in adipose tissue.
Topics: Adipocytes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Dose-Response Relationship, Drug; Humans; Lipid Metabolism; Lipolysis; Male; Middle Aged; Obesity; Receptor, Angiotensin, Type 1; Subcutaneous Fat, Abdominal | 2007 |
Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Cell Differentiation; Chemokine CCL2; Humans; Male; NF-kappa B; Nitriles; Obesity; Promoter Regions, Genetic; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfones; Tetrazoles; Thiocarbamates; Transcription, Genetic; Valine; Valsartan | 2006 |
An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
Topics: Adipocytes; Angiotensin II; Animals; Animals, Newborn; Autocrine Communication; Cardiomegaly; Cells, Cultured; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Leptin; MAP Kinase Signaling System; Myocytes, Cardiac; Obesity; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2006 |
Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.
Topics: Adaptor Proteins, Signal Transducing; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Enzyme Activation; Fatty Liver; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Irbesartan; Male; Mitogen-Activated Protein Kinase 3; Obesity; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker; Receptor, Insulin; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tetrazoles | 2006 |
Increased aldosterone/renin quotient in obese hypertensive women: a novel role for low-density lipoproteins?
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Glucose; Cells, Cultured; Female; Humans; Hypertension; Insulin; Lipoproteins, LDL; Middle Aged; Obesity; Renin | 2006 |
Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cells, Cultured; Female; Gene Expression Regulation; Imidazoles; Kidney Diseases; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Oxidative Stress; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; RNA, Messenger; Serum Amyloid A Protein; Signal Transduction; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Adiponectin versus angiotensin II: Key pathological role of their misbalance.
Topics: Adiponectin; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Obesity; Reactive Oxygen Species; Signal Transduction | 2006 |
Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Body Weight; Endothelial Cells; Endothelin-1; Enzyme Inhibitors; In Vitro Techniques; Losartan; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitroprusside; Obesity; Potassium Chloride; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blotting, Western; Cholesterol; Dietary Fats; Endothelin-1; Endothelium, Vascular; Gene Expression; Glucose Tolerance Test; Hydroxyl Radical; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Obesity; Receptors, Angiotensin; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Endocrine role of the renin-angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation.
Topics: Abdomen; Adipose Tissue; Angiotensin II; Angiotensinogen; Humans; Male; Middle Aged; Muscle, Skeletal; Obesity; Receptors, Adrenergic, beta; Regional Blood Flow; Renin-Angiotensin System | 2007 |
The metabolic syndrome and the risk of thrombosis.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Anthropometry; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Cytokines; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Metabolic Syndrome; Obesity; Plasminogen; Prevalence; Prospective Studies; Risk Factors; Stroke; Thrombophilia; Thrombosis; Tissue Plasminogen Activator | 2007 |
Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production.
Topics: Angiotensin II; Animals; Aorta; Blotting, Western; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation; GTP Cyclohydrolase; Insulin Resistance; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Quinolines; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Superoxides | 2007 |
Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization.
Topics: Angiotensin II; Animals; Drug Resistance; Glucose; Hypothalamo-Hypophyseal System; Leptin; Male; Metabolic Clearance Rate; Obesity; Pituitary-Adrenal System; Rats; Rats, Zucker | 2007 |
Larger anti-adipogenic effect of angiotensin II on omental preadipose cells of obese humans.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Body Composition; Cell Differentiation; Energy Intake; Energy Metabolism; Humans; Obesity; Omentum; Stromal Cells | 2007 |
DOCA stimulates salt appetite in Zucker rats: effect of dose, synergistic action with central angiotensin II, and obesity.
Topics: Aldosterone; Analysis of Variance; Angiotensin II; Animals; Appetite Regulation; Behavior, Animal; Desoxycorticosterone; Dose-Response Relationship, Drug; Drinking; Drinking Behavior; Drug Administration Routes; Drug Synergism; Eating; Male; Mineralocorticoids; Obesity; Rats; Rats, Zucker; Sodium Chloride; Time Factors; Vasoconstrictor Agents | 2007 |
Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat.
Topics: Angiotensin II; Animals; Blood Pressure; Diet, Sodium-Restricted; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Insulin Resistance; Kidney Diseases; Mesenteric Artery, Superior; Norepinephrine; Obesity; Prediabetic State; Rats; Rats, Zucker; Renal Artery; Renal Circulation; Renin; Renin-Angiotensin System; Vasoconstriction; Vasoconstrictor Agents | 2007 |
Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin.
Topics: Adipose Tissue; Angiotensin II; Animals; Basal Metabolism; Diacylglycerol O-Acyltransferase; Dietary Fats; Energy Metabolism; Insulin; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Phenotype; Renin; Thinness | 2007 |
[Study on the correlation between hypertension and the indexes of vascular endothelial function among people living in the community].
Topics: Adult; Age Factors; Aged; Angiotensin II; Cluster Analysis; Endothelium, Vascular; Epoprostenol; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Obesity; Overweight; Prevalence; Risk Factors | 2007 |
Preglomerular and postglomerular basal diameter changes and reactivity to angiotensin II in obese rats.
Topics: Angiotensin II; Animals; Arterioles; Dose-Response Relationship, Drug; Hydronephrosis; Kidney Glomerulus; Male; Microcirculation; Obesity; Rats; Rats, Zucker; Tissue Culture Techniques; Vascular Resistance; Vasoconstrictor Agents | 2008 |
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |
Regional heterogeneity of functional changes in conduit arteries after high-fat diet.
Topics: Acetylcholine; Angiotensin II; Animals; Atherosclerosis; Carotid Arteries; Dietary Fats; Endothelin-1; Femoral Artery; Hydroxyl Radical; Male; Mice; Mice, Inbred C57BL; Obesity; Reactive Oxygen Species; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2008 |
Chronic candesartan alters expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat.
Topics: Amiloride; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blotting, Western; Diuretics; Epithelial Sodium Channels; Furosemide; Hypertrophy; Kidney Tubules, Proximal; Male; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptors, Drug; Renin; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Phosphate Cotransporter Proteins, Type IIb; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Symporters; Tetrazoles | 2008 |
Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Body Weight; Captopril; Cardiovascular Diseases; Drug Evaluation, Preclinical; Glucose; Heart; Insulin; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Myocardium; Obesity; Organ Culture Techniques; Organ Size; Oxygen Consumption; Signal Transduction | 2008 |
[Hypertension: pathogenetic factors, evaluation and risk factors].
Topics: Aged; Angiotensin II; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Renin; Risk | 1981 |
Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension.
Topics: Adult; Angiotensin II; Blood Pressure; Female; Glucose; Glucose Clamp Technique; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Muscle, Smooth, Vascular; Obesity; Pressoreceptors; Sodium, Dietary | 1994 |
The renin-angiotensin system in the type II diabetic obese Zucker rat.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; In Vitro Techniques; Male; Norepinephrine; Obesity; Rats; Rats, Zucker; Renin; Renin-Angiotensin System; Vasoconstriction | 1993 |
Angiotensin II in brown adipose tissue from young and adult Zucker obese and lean rats.
Topics: Adipose Tissue, Brown; Aging; Angiotensin II; Animals; Female; Male; Neurons; Norepinephrine; Obesity; Rats; Rats, Zucker; Reference Values; Renin-Angiotensin System | 1994 |
Impaired recovery of vascular smooth muscle intracellular calcium following agonist stimulation in insulin resistant (Zucker obese) rats.
Topics: Angiotensin II; Animals; Aorta; Arginine Vasopressin; Calcium; Calcium-Transporting ATPases; Cells, Cultured; Fluorometry; Fura-2; Hypertension; Insulin; Insulin Resistance; Male; Muscle, Smooth, Vascular; Obesity; Rats; Rats, Zucker; Sarcoplasmic Reticulum; Time Factors; Vasoconstriction; Vasodilation | 1993 |
Renal angiotensin receptor mapping in obese spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Autoradiography; Binding Sites; Female; Glomerular Mesangium; Kidney; Male; Obesity; Rats; Rats, Inbred SHR; Receptors, Angiotensin | 1993 |
Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity.
Topics: Adolescent; Adult; Angiotensin II; Angiotensinogen; Base Sequence; Blood Pressure; Body Mass Index; Female; Genotype; Homozygote; Humans; Hypertension; Infusions, Intravenous; Kidney; Male; Middle Aged; Molecular Sequence Data; Obesity; Oligonucleotide Probes; Pedigree; Renal Artery; Renal Plasma Flow; Vascular Resistance; Vasoconstrictor Agents | 1996 |
[Heart hypertrophy. Determinant factors and molecular mechanisms].
Topics: Adult; Age Factors; Aged; Angiotensin II; Cardiomegaly; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Obesity; Racial Groups; Risk Factors; Sex Factors; Thyroid Hormones | 1995 |
Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Hemodynamics; Imidazoles; Infusions, Intravenous; Kidney; Losartan; Male; Obesity; Prazosin; Rats; Rats, Zucker; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Sympathetic Nervous System; Tetrazoles | 1996 |
Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells.
Topics: 3T3 Cells; Adipose Tissue; Angiotensin II; Animals; Fatty Acid Synthases; Gene Expression Regulation, Enzymologic; Glycerolphosphate Dehydrogenase; Humans; Kinetics; Lipids; Mice; Obesity; RNA, Messenger; Triglycerides | 1997 |
Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.
Topics: Alleles; Angiotensin II; Asian People; Comorbidity; Coronary Disease; Diabetes Mellitus; Ethnicity; Female; Genetic Variation; Genotype; Humans; Hypercholesterolemia; Hypertension; Korea; Male; Mass Screening; Middle Aged; Obesity; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Postmenopause; Risk Factors; Sequence Deletion; Sex Characteristics; Smoking | 1997 |
[Clinical characteristics and follow-up of patients attending a hospital hypertension clinic. 10-year experience].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Data Interpretation, Statistical; Diabetes Complications; Diuretics; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Obesity; Outpatients; Risk Factors; Time Factors | 1999 |
Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Carotid Arteries; Cholesterol; Cyclooxygenase Inhibitors; Diet; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression Regulation, Enzymologic; Humans; Indomethacin; Kidney; Lung; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Culture Techniques; Peptidyl-Dipeptidase A; Phenylpropionates; Protein Binding; Pyrimidines; Receptor, Endothelin A; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2000 |
Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Carotid Arteries; Circadian Rhythm; Diabetes Mellitus; Diabetes Mellitus, Type 2; Ganglionic Blockers; Heart Rate; Hexamethonium; Hypertension; Losartan; Male; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sodium Chloride, Dietary; Sympathetic Nervous System; Vasoconstriction | 2000 |
Brain angiotensin type 1 receptor expression and function in the Zucker obese rat.
Topics: Angiotensin II; Animals; Blood Pressure; Brain; Injections, Intraventricular; Male; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger | 2000 |
Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance.
Topics: Adult; Angiotensin II; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Human Growth Hormone; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Leptin; Male; Middle Aged; Obesity; Risk Factors; Tumor Necrosis Factor-alpha | 2001 |
Obese female SHHF/Mcc-fa(cp) rats resist antihypertensive effects of renin-angiotensin system inhibition.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Resistance; Female; Irbesartan; Obesity; Rats; Rats, Mutant Strains; Renin; Renin-Angiotensin System; Sex Characteristics; Tetrazoles; Thinness; Time Factors | 2001 |
Effect of angiotensin peptides on PAI-1 expression and production in human adipocytes.
Topics: Adipocytes; Adult; Angiotensin II; Angiotensin III; Cells, Cultured; Female; Fibrinolysis; Gene Expression; Humans; Hypertension; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System | 2001 |
[Effects of anti-atherosclerotic low-sodium diet on dynamics of natural antibodies to angiotensin II, bradykinin and vasopressin in blood of patients with hypertension and obesity].
Topics: Adult; Angiotensin II; Arteriosclerosis; Bradykinin; Diet, Sodium-Restricted; Female; Humans; Hypertension; Immunoenzyme Techniques; Male; Middle Aged; Obesity; Vasopressins | 2001 |
Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Angiotensin II; Animals; Culture Media, Serum-Free; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Down-Regulation; Growth Hormone; Hormones, Ectopic; Intercellular Signaling Peptides and Proteins; Mice; Mitogen-Activated Protein Kinases; Nerve Growth Factor; Obesity; Proteins; Resistin; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha | 2001 |
Elevated AT1 receptor protein but lower angiotensin II-binding in adipose tissue of rats with monosodium glutamate-induced obesity.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adipose Tissue; Angiotensin II; Animals; Animals, Newborn; Cell Membrane; Male; Obesity; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; RNA, Messenger; Sodium Glutamate | 2001 |
Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats.
Topics: Angiotensin II; Animals; Arteries; Arterioles; Blood Pressure; Diabetes Mellitus; Endothelins; Heart Rate; Hypertension; Male; Microcirculation; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Obesity; Phentolamine; Propranolol; Rats; Rats, Zucker; Thinness; Vasoconstriction | 2002 |
Inactive renin in human plasma.
Topics: Angiotensin II; Humans; Hypertension; Obesity; Renin | 1976 |
Starvation---an interesting model for the study of the renin-angiotensin-aldosterone system.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Creatinine; Female; Glucose; Glucosephosphate Dehydrogenase; Humans; Obesity; Radioimmunoassay; Renin; Starvation | 1978 |
[New findings on the behavior of the renin-angiotensin-aldosterone system in obesity].
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Circadian Rhythm; Female; Furosemide; Humans; Male; Obesity; Renin | 1978 |
Short-term hormonal control of hepatic carbohydrate and lipid catabolism.
Topics: Angiotensin II; Animals; Diabetes Mellitus; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerides; Hormones; Insulin; Liver; Liver Glycogen; Nucleotides, Cyclic; Obesity; Oxytocin; Parathyroid Hormone; Protein Kinases; Starvation; Stress, Physiological; Vasopressins | 1977 |
Short-term hormonal control of fat metabolism in the liver [proceedings].
Topics: Acyl Coenzyme A; Angiotensin II; Animals; Diabetes Mellitus; Epinephrine; Fatty Acids; Hormones; Lipid Metabolism; Liver; Mice; Obesity | 1977 |
Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support.
Topics: Angiotensin II; Animals; Chlorisondamine; Diastole; Heart Rate; Hypertension; Insulin Resistance; Male; Norepinephrine; Obesity; Rats; Rats, Zucker; Sympathetic Nervous System; Systole | 1992 |
Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Female; Insulin; Male; Obesity; Reference Values | 1990 |
Hypertension in pseudohypoparathyroidism type I.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Catecholamines; Child; Female; Humans; Hydrocortisone; Hypertension; Male; Obesity; Parathyroid Hormone; Posture; Pseudohypoparathyroidism; Renin | 1988 |
Does chronic hyperinsulinemia cause hypertension?
Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Chronic Disease; Dogs; Hyperinsulinism; Hypertension; Natriuresis; Obesity | 1989 |
Fasting in obese females. II. Plasma renin activity and urinary aldosterone.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Fasting; Female; Glucose; Humans; Middle Aged; Obesity; Potassium; Renin; Sodium; Water-Electrolyte Balance | 1968 |
[Sodium excretion in obese juveniles].
Topics: Adolescent; Adult; Angiotensin II; Female; Humans; Obesity; Sodium | 1968 |
Sodium excretion in obese adolescents.
Topics: Adolescent; Adult; Angiotensin II; Calorimetry; Diet; Female; Glomerular Filtration Rate; Humans; Infusions, Parenteral; Natriuresis; Obesity; Sodium Chloride; Water-Electrolyte Balance | 1968 |
[Aspects of adrenal cortex function in obesity. VI. The behavior of aldosterone secretion and secretion of its metabolites during some dynamic tests].
Topics: Adolescent; Adrenal Glands; Adult; Aldosterone; Angiotensin II; Female; Humans; Male; Middle Aged; Obesity; Pituitary-Adrenal Function Tests; Radioisotope Dilution Technique; Sodium Chloride | 1968 |
Fasting in obese females: plasma renin after glucose refeeding.
Topics: Angiotensin II; Fasting; Female; Glucose; Humans; Nutritional Physiological Phenomena; Obesity; Renin | 1973 |